Can-Fite BioPharma (CANF) Research & Development (2012 - 2023)
Can-Fite BioPharma (CANF) reported Research & Development of $6.69 million for FY2025, up 16.3% from $5.76 million in FY2024.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Research & Development (2012 - 2023) Analysis & Trends
Dating back to FY2009, Can-Fite BioPharma's Research & Development record includes 16 years.
- Research & Development has a five-year compound annual growth rate of -10.9% (FY2020 to FY2025).
- The FY2025 figure ranks as the highest annual Research & Development since FY2021.
- According to Business Quant data, Research & Development came in at $5.76 million in FY2024 (-3.8%), $5.98 million in FY2023 (unchanged), $5.98 million in FY2022 (-39.3%) and $9.85 million in FY2021 (-17.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Can-Fite BioPharma | 1.36 Mn | -18.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 1.27 Mn |
| Sep 30, 2023 | 1.30 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 2.06 Mn |
| Dec 31, 2022 | 674,000.00 |
| Sep 30, 2022 | 2.04 Mn |
| Jun 30, 2022 | 1.45 Mn |
| Mar 31, 2022 | 1.82 Mn |
| Dec 31, 2021 | 3.10 Mn |
| Sep 30, 2021 | 2.94 Mn |
| Jun 30, 2021 | 2.51 Mn |
| Mar 31, 2021 | 1.30 Mn |
| Dec 31, 2020 | 2.90 Mn |
| Sep 30, 2020 | 2.00 Mn |
| Jun 30, 2020 | 3.28 Mn |
| Dec 31, 2019 | 3.96 Mn |
| Sep 30, 2019 | 3.06 Mn |
| Jun 30, 2019 | 2.52 Mn |
| Mar 31, 2019 | 1.44 Mn |
| Dec 31, 2018 | 2.02 Mn |
API Access
Can-Fite BioPharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();